Differential regulation of FADS2 by EZH2 reveals a metabolic vulnerability in ovarian cancer treatment

Lixiang Xue(Peking University)
EBioMedicine
August 18, 2025
10.1016/j.ebiom.2025.105879
Cited by 1

Related Papers

EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
|Molecular Cancer Research|2014|69
Dysregulated lipid metabolism blunts the sensitivity of cancer cells to EZH2 inhibitor
|EBioMedicine|2022|42
Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway.
|PubMed|2017|18
Supplementary Methods, Figures 1 - 3, Tables 1 - 3 from EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
|Unknown|2023|0
Supplementary Methods, Figures 1 - 3, Tables 1 - 3 from EZH2 Represses Target Genes through H3K27-Dependent and H3K27-Independent Mechanisms in Hepatocellular Carcinoma
|Unknown|2023|0